Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Villeneuve

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
L'Union Medicale Du Canada|December 1, 1984
[Immunoprophylaxis of hepatitis B]J P Villeneuve
The American Journal of Gastroenterology|August 13, 1999
Risk factors for the development of bacterial infections in hospitalized patients with cirrhosisM Deschênes, J P Villeneuve
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 6, 2000
Fulminant hepatitis A in patients with chronic liver diseaseP Lefilliatre, J P Villeneuve
Current Drug Metabolism|June 8, 2004
Cytochrome P450 and liver diseasesJ-P Villeneuve, V Pichette
The Review of Scientific Instruments|October 1, 1978
Laboratory systems for measuring short-term changes in water levelsJ P Villeneuve, Y Ouellet
Annals of Internal Medicine|August 1, 1979
Intravascular coagulation and ascitic-fluid infusionA Viallet, J P Villeneuve
Lancet (London, England)|August 24, 1996
Terfenadine-induced cholestatic hepatitisA Sahai, J P Villeneuve
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 1, 1996
Hepatitis after the use of germander, a herbal remedyL Laliberté, J P Villeneuve
Hepatology (Baltimore, Md.)|November 1, 1983
Determinants of drug disposition in patients with cirrhosisP M Huet, J P Villeneuve
Clinical Neuropharmacology|March 1, 1983
Hypermetabolism of phenytoin as a cause of treatment failureL H Lebrun, J P Villeneuve
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
L'Union Medicale Du Canada|December 1, 1984
[Immunoprophylaxis of hepatitis B]J P Villeneuve
The American Journal of Gastroenterology|August 13, 1999
Risk factors for the development of bacterial infections in hospitalized patients with cirrhosisM Deschênes, J P Villeneuve
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 6, 2000
Fulminant hepatitis A in patients with chronic liver diseaseP Lefilliatre, J P Villeneuve
Current Drug Metabolism|June 8, 2004
Cytochrome P450 and liver diseasesJ-P Villeneuve, V Pichette
The Review of Scientific Instruments|October 1, 1978
Laboratory systems for measuring short-term changes in water levelsJ P Villeneuve, Y Ouellet
Annals of Internal Medicine|August 1, 1979
Intravascular coagulation and ascitic-fluid infusionA Viallet, J P Villeneuve
Lancet (London, England)|August 24, 1996
Terfenadine-induced cholestatic hepatitisA Sahai, J P Villeneuve
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 1, 1996
Hepatitis after the use of germander, a herbal remedyL Laliberté, J P Villeneuve
Hepatology (Baltimore, Md.)|November 1, 1983
Determinants of drug disposition in patients with cirrhosisP M Huet, J P Villeneuve
Clinical Neuropharmacology|March 1, 1983
Hypermetabolism of phenytoin as a cause of treatment failureL H Lebrun, J P Villeneuve
Pageof 12